85 related articles for article (PubMed ID: 38667168)
21. Modern biomarkers in prostate cancer diagnosis.
Porzycki P; Ciszkowicz E
Cent European J Urol; 2020; 73(3):300-306. PubMed ID: 33133657
[TBL] [Abstract][Full Text] [Related]
22. The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.
Messner EA; Steele TM; Tsamouri MM; Hejazi N; Gao AC; Mudryj M; Ghosh PM
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33076388
[TBL] [Abstract][Full Text] [Related]
23. Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review.
Tian S; Lei Z; Gong Z; Sun Z; Xu D; Piao M
Cancer Cell Int; 2020; 20():409. PubMed ID: 32863768
[TBL] [Abstract][Full Text] [Related]
24. Clinical Applications of Molecular Biomarkers in Prostate Cancer.
Couñago F; López-Campos F; Díaz-Gavela AA; Almagro E; Fenández-Pascual E; Henríquez I; Lozano R; Linares Espinós E; Gómez-Iturriaga A; de Velasco G; Quintana Franco LM; Rodríguez-Melcón I; López-Torrecilla J; Spratt DE; Guerrero LL; Martínez-Salamanca JI; Del Cerro E
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545454
[TBL] [Abstract][Full Text] [Related]
25. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
Marusyk A; Janiszewska M; Polyak K
Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment.
Kregel S; Wang C; Han X; Xiao L; Fernandez-Salas E; Bawa P; McCollum BL; Wilder-Romans K; Apel IJ; Cao X; Speers C; Wang S; Chinnaiyan AM
Neoplasia; 2020 Feb; 22(2):111-119. PubMed ID: 31931431
[TBL] [Abstract][Full Text] [Related]
27. Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer.
Rice MA; Malhotra SV; Stoyanova T
Front Oncol; 2019; 9():801. PubMed ID: 31555580
[TBL] [Abstract][Full Text] [Related]
28. Cell-based biosensors: Recent trends, challenges and future perspectives.
Gupta N; Renugopalakrishnan V; Liepmann D; Paulmurugan R; Malhotra BD
Biosens Bioelectron; 2019 Sep; 141():111435. PubMed ID: 31238280
[TBL] [Abstract][Full Text] [Related]
29. Genomic correlates of clinical outcome in advanced prostate cancer.
Abida W; Cyrta J; Heller G; Prandi D; Armenia J; Coleman I; Cieslik M; Benelli M; Robinson D; Van Allen EM; Sboner A; Fedrizzi T; Mosquera JM; Robinson BD; De Sarkar N; Kunju LP; Tomlins S; Wu YM; Nava Rodrigues D; Loda M; Gopalan A; Reuter VE; Pritchard CC; Mateo J; Bianchini D; Miranda S; Carreira S; Rescigno P; Filipenko J; Vinson J; Montgomery RB; Beltran H; Heath EI; Scher HI; Kantoff PW; Taplin ME; Schultz N; deBono JS; Demichelis F; Nelson PS; Rubin MA; Chinnaiyan AM; Sawyers CL
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11428-11436. PubMed ID: 31061129
[TBL] [Abstract][Full Text] [Related]
30. Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.
Esther J; Maughan BL; Anderson N; Agarwal N; Hahn AW
Curr Treat Options Oncol; 2019 Feb; 20(2):14. PubMed ID: 30741354
[TBL] [Abstract][Full Text] [Related]
31. Integrative single-cell analysis.
Stuart T; Satija R
Nat Rev Genet; 2019 May; 20(5):257-272. PubMed ID: 30696980
[TBL] [Abstract][Full Text] [Related]
32. Microfluidic active loading of single cells enables analysis of complex clinical specimens.
Calistri NL; Kimmerling RJ; Malinowski SW; Touat M; Stevens MM; Olcum S; Ligon KL; Manalis SR
Nat Commun; 2018 Nov; 9(1):4784. PubMed ID: 30429479
[TBL] [Abstract][Full Text] [Related]
33. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.
Aggarwal R; Huang J; Alumkal JJ; Zhang L; Feng FY; Thomas GV; Weinstein AS; Friedl V; Zhang C; Witte ON; Lloyd P; Gleave M; Evans CP; Youngren J; Beer TM; Rettig M; Wong CK; True L; Foye A; Playdle D; Ryan CJ; Lara P; Chi KN; Uzunangelov V; Sokolov A; Newton Y; Beltran H; Demichelis F; Rubin MA; Stuart JM; Small EJ
J Clin Oncol; 2018 Aug; 36(24):2492-2503. PubMed ID: 29985747
[TBL] [Abstract][Full Text] [Related]
35. Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation.
Cetin AE; Stevens MM; Calistri NL; Fulciniti M; Olcum S; Kimmerling RJ; Munshi NC; Manalis SR
Nat Commun; 2017 Nov; 8(1):1613. PubMed ID: 29151572
[TBL] [Abstract][Full Text] [Related]
36. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
37. On the origin and impact of mesenchymal stem cell heterogeneity: new insights and emerging tools for single cell analysis.
McLeod CM; Mauck RL
Eur Cell Mater; 2017 Oct; 34():217-231. PubMed ID: 29076514
[TBL] [Abstract][Full Text] [Related]
38. Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.
Bluemn EG; Coleman IM; Lucas JM; Coleman RT; Hernandez-Lopez S; Tharakan R; Bianchi-Frias D; Dumpit RF; Kaipainen A; Corella AN; Yang YC; Nyquist MD; Mostaghel E; Hsieh AC; Zhang X; Corey E; Brown LG; Nguyen HM; Pienta K; Ittmann M; Schweizer M; True LD; Wise D; Rennie PS; Vessella RL; Morrissey C; Nelson PS
Cancer Cell; 2017 Oct; 32(4):474-489.e6. PubMed ID: 29017058
[TBL] [Abstract][Full Text] [Related]
39. Tumour heterogeneity poses a significant challenge to cancer biomarker research.
Cyll K; Ersvær E; Vlatkovic L; Pradhan M; Kildal W; Avranden Kjær M; Kleppe A; Hveem TS; Carlsen B; Gill S; Löffeler S; Haug ES; Wæhre H; Sooriakumaran P; Danielsen HE
Br J Cancer; 2017 Jul; 117(3):367-375. PubMed ID: 28618431
[TBL] [Abstract][Full Text] [Related]
40. Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.
Weitsman G; Mitchell NJ; Evans R; Cheung A; Kalber TL; Bofinger R; Fruhwirth GO; Keppler M; Wright ZVF; Barber PR; Gordon P; de Koning T; Wulaningsih W; Sander K; Vojnovic B; Ameer-Beg S; Lythgoe M; Arnold JN; Årstad E; Festy F; Hailes HC; Tabor AB; Ng T
Oncogene; 2017 Jun; 36(25):3618-3628. PubMed ID: 28166195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
